Michael Cloonan

Chief Executive Officer at Sionna Therapeutics, Inc.

53 year

Health Technology

Consumer Services

Finance

Profile

Michael Cloonan is Chief Operating Officer of SAGE Therapeutics, Inc. In the past he held the position of Senior Vice President-US Commercial at Biogen, Inc. Mr. Cloonan received an MBA from the University of Virginia Darden School of Business and an undergraduate degree from College of the Holy Cross (Massachusetts).

Michael Cloonan active positions

Companies	Position	Start
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA.	Consultant / Advisor	-
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan.	Chief Executive Officer	-

All active positions of Michael Cloonan

Former positions of Michael Cloonan

Companies	Position	End
SAGE THERAPEUTICS, INC.	Chief Operating Officer	2021-05-02
BIOGEN INC.	Corporate Officer/Principal	2016-12-31

See the detail of Michael Cloonan's experience

Training of Michael Cloonan

College of the Holy Cross (Massachusetts)	Undergraduate Degree
University of Virginia Darden School of Business	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Cloonan's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
BIOGEN INC.	Health Technology
SAGE THERAPEUTICS, INC.	Health Technology

Private companies	2
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA.	Finance
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan.	Health Services